January 31, 2024 · Form 4 insider transaction
Kim Dong bought 12,000 shares of UROGEN PHARMA LTD at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.; 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.